Market is led by established players (Novartis, copyright, bluebird bio, Bristol-Myers Squibb) while emerging innovators like Agios, Beam, Editas, CRISPR Therapeutics, and Vertex are advancing new disease-modifying options . https://www.datamintelligence.com/research-report/sickle-cell-disease-treatment-market